Article Details
Retrieved on: 2025-01-19 12:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ALX Oncology Holdings Inc. (NASDAQ:ALXO), a biopharmaceutical company currently valued at $93.36 million, has announced the adoption of a new ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here